Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cell-Based Influenza Vaccine (Vaccine Industrial Holding)
- Development stage
- Preclinical
- Lead developer
- CSL Seqirus
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
This cell-based influenza vaccine is a prophylactic vaccine being developed and localized in Saudi Arabia by Vaccine Industrial Holding (VIC) in partnership with CSL Seqirus and the Saudi Ministry of Health. Unlike traditional influenza vaccines produced in embryonated chicken eggs, this vaccine utilizes a mammalian cell-culture manufacturing platform. This technology offers several advantages, including the avoidance of egg-adaptive mutations that can reduce vaccine effectiveness, a faster manufacturing turnaround time during pandemic threats, and suitability for individuals with egg allergies. The project is part of a strategic initiative to enhance Saudi Arabia's national health security and vaccine self-sufficiency.
- Other names
- VIC Cell-Based Influenza VaccineVaccine Industrial Holding Influenza Vaccine
02
Targets
HA (Hemagglutinin)Neuraminidase
Beyond the preview
Go deeper on Cell-Based Influenza Vaccine (Vaccine Industrial Holding).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cell-Based Influenza Vaccine (Vaccine Industrial Holding).